SLQT Earnings

SLQT reported its earnings on 2026-02-05, showcasing a revenue of 537.10M against an estimate of 520.00M, resulting in a 3.29% surprise. The EPS was 0.26, surpassing the expected 0.17 by 52.94%. The stock experienced a -28.97% price change on the earnings day and a -37.45% change over the next five days, reflecting market reactions to the results.

Following SLQT's earnings announcement on 2026-02-05, the stock price moved by -28.97% on the day of the release. Over the subsequent five days, it saw a -37.45% change. Historically, SLQT's stock price tends to shift by an average of 19.23% in the 10 days leading up to earnings and -4.43% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate SLQT's annual revenue to reach 465.45M, while the EPS is projected at 0.08. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between SLQT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SLQT's stock price typically moves by 19.23% in the 10 days before its earnings and -4.43% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 0.08 and revenue of 465.45M.

The earnings call reveals strong financial performance, with a 12% revenue growth and 26% increase in Healthcare Services revenue. The company maintains a stable fiscal 2026 outlook and anticipates positive cash flow. Despite increased competition in life insurance, the company has strong operational execution and marketing efficiency. The new PBM deal offers stability, and the strategic plan for Medicare Advantage is promising. The Q&A section supports management's confidence, with positive analyst sentiment, suggesting a likely positive stock price movement in the short term.